Skip to content
Search

Latest Stories

New polymer £50 note featuring Alan Turing enters circulation

The new polymer £50 note featuring the scientist Alan Turing today (23 June) entered circulation. The new note will be available in bank branches and at ATM’s in the coming days.

The last day to use paper £20 and £50 notes will be 30 September 2022. These notes will no longer be legal tender after that.


The polymer £50 note contains advanced security features, completing Bank of England’s set of polymer banknotes. The note will join the Churchill £5, the Austen £10 and the Turner £20, meaning all Bank of England banknotes are now available on polymer.

Speaking as the note entered circulation, the Bank of England’s Chief Cashier Sarah John said: “The polymer £50 note is the most secure Bank of England banknote yet, and the features of the note make it very difficult to counterfeit.

BOE NOTE Sample image of the new 50 pound note, featuring late mathematician Alan Turing obtained March 25, 2021. Bank of England/Handout via REUTERS

"All of our polymer banknotes can be checked by looking for two key security features: a hologram which changes image; and see-through windows. So if you can check one denomination of banknote, you can check them all. The new £50 notes, like the polymer £10 and £20 notes, contain a tactile feature to help vision impaired people identify the denomination.”

Retailers have been urged to ensure that they aware of the new note’s security features as it begins to be used by customers. Further details about the new £50 note are available at www.new50.co.uk.

The Bank of England offers a free Banknote Checking Scheme which is open to businesses and retailers, more information can be found here.

More For You

NHS to roll out RSV vaccinations across 200 pharmacies in 2025/26

NHS England aims to ensure that everyone aged 75 to 79 years old is offered RSV vaccination by 31 August 2025.

Photo credit: gettyimages

RSV vaccination pilot to expand to 200 pharmacies in 2025/26

As part of its public health functions for 2025/26, NHS England plans to expand the Respiratory Syncytial Virus (RSV) immunisation programme to include up to 200 community pharmacies in targeted areas.

This follows the launch of an early adopter initiative in September 2024, where 50 community pharmacy sites in the East of England were commissioned to offer RSV vaccinations.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less